Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

TLV and Emergent BioSolutions to codevelop H5 influenza vaccine

Aug. 16, 2010

Allozyne partners with Sigma-Aldrich for cycloaddition chemistry

Aug. 16, 2010

PregLem inlicenses bentamapimod from Merck Serono for postoperative adhesions and endometriosis

Aug. 13, 2010

NeoStem and Schepens Eye Research Institute enter agreement for retinal diseases

Aug. 13, 2010

ACT and Brown Cancer Center collaborate to identify cancer therapeutics

Aug. 12, 2010

Crucell, IAVI and BIDMC to conduct phase I AdVac-based AIDS vaccine trial

Aug. 12, 2010

NsGene and Biogen Idec sign new agreement for artemin

Aug. 11, 2010

Scancell and Cancer Research Technology sign antibody license agreement

Aug. 11, 2010

Vectura and GSK sign license agreement for dry powder drug formulations

Aug. 10, 2010

Impax Laboratories and Perrigo collaborate on topical drug products

Aug. 9, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.